Date | Product | Disease | Phase | Company | Therapeutic area |
---|---|---|---|---|---|
2015-05-29 | AMG 416 | secondary hyperparathyroidism in patients with chronic kidney disease (CKD) receiving hemodialysis | 3 | Amgen (USA - CA) | Hormonal diseases - Endocrine diseases - Renal diseases - Kidney diseases |
2015-05-29 | AMV-564 (formerly T564) | acute myeloid leukemia (AML) | preclinical | Affimed (Germany) | Cancer - Oncology |
2015-05-28 | SER-109 - encapsulated spores from fecal microbiota | prevention of recurrent Clostridium difficile infection (CDI) in adults | 2 | Seres Therapeutics (USA - MA) | Infectious diseases |
2015-05-28 | Xarelto® (rivaroxaban) | prevention and treatment of pulmonary embolism and deep vein thrombosis in patients with various types of cancer | 3 | Bayer Healthcare (Germany) Janssen Pharmaceuticals, a J&J company (USA - NJ) | Cancer - Oncology - Cardiovascular diseases |
2015-05-28 | belinostat | 1 | Onxeo (France) | Cancer - Oncology | |
2015-05-28 | belinostat | thymic epithelial tumors | 1-2 | Onxeo (France) | Cancer - Oncology |
2015-05-28 | Cx611 | sepsis | 1 | TiGenix (Belgium) | Infectious diseases |
2015-05-28 | belinostat | soft tissue sarcoma | 2 | Topotarget (Denmark) | Cancer - Oncology |
2015-05-27 | KH176 - (S)-6-hydroxy-2,5,7,8-tetramethyl-N-((R)-piperidin-3-yl)chroman-2-carboxamide hydrochloride | mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS syndrome), Leber\'s hereditary optic neuropathy (LHON), Leigh syndrome, mitochondrial disease, mitochondrial DNA tRNALeu(UUR) m.3243A1 |
Khondrion (The Netherlands) |
Rare diseases - Genetic diseases |
|
2015-05-27 | MGD006 | non clinical | Macrogenics (USA - MD) | Cancer - Oncology | |
2015-05-26 | talimogene laherparepvec | unresected stage IIIB, IIIC or IV melanoma | 3 | Amgen (USA - CA) | Cancer - Oncology |
2015-05-26 | JVS-100 | ischemic heart failure |
2 | Juventas Therapeutics (USA - OH) Biocardia (USA - CA) | Cardiovascular diseases |
2015-05-26 | lomitapide | homozygous familial hypercholesterolemia (HoFH) |
3 | Aegerion Pharmaceuticals (USA - MA) | Rare diseases - Genetic diseases - Metabolic diseases |
2015-05-26 | DCVAC/PCa | prostate cancer | 3 | Sotio (Czech Republic) | Cancer - Oncology |
2015-05-26 | Bruton\'s Tyrosine Kinase (BTK) inhibitor | blood cancers, autoimmune diseases | RedXPharma (UK) | Autoimmune diseases - Cancer - Oncology | |
2015-05-25 | RTU-1096 | psoriasis |
1 | R-Tech Ueno (Japan) | Autoimmune diseases - Dermatological diseases |
2015-05-23 | BAY 80-6946 - copanlisib | mantle cell lymphoma | 2 | Bayer Healthcare (Germany) | Cancer - Oncology |
2015-05-21 | AU-011 - modified human papillomavirus capsid protein conjugated to a near infrared dye | uveal melanoma |
preclinical | Aura Biosciences (USA - MA) | Cancer - Oncology |
2015-05-20 | QVA149 (indacaterol/glycopyrronium bromide) | chronic obstructive pulmonary disease (COPD) | 3 | Novartis (Switzerland) | Allergic diseases - Inflammatory diseases - Respiratory diseases |
2015-05-20 | Xarelto® (rivaroxaban) | atrial fibrillation | 3 | Bayer Healthcare (Germany) Janssen Pharmaceuticals, a J&J company (USA - NJ) | Cardiovascular diseases |